This book provides the latest research and developments in the field of metronomic chemotherapy for breast cancer. It presents the principles and mechanisms of metronomic chemotherapy, preclinical and clinical studies, and the latest developments in drug delivery systems and nanoformulations. The clinical pharmacology of metronomic chemotherapy, including pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions, are also examined.
Key Features:
Introduces metronomics therapy in the neoadjuvant and adjuvant treatment of breast cancer Explores the potential of metronomics in terms of personalized chemotherapy Present pharmacological bases of metronomic chemotherapy Covers the latest developments in drug delivery systems, nanotechnology, and nanoformulations Discusses antiangiogenic effects and the impact of metronomics on immunity
This book is useful for students, researchers, oncologists, pharmacologists, and healthcare experts interested in understanding the clinical potential of metronomic chemotherapy in breast cancer.
Edited by:
Manzoor Ahmad Mir
Imprint: CRC Press
Country of Publication: United Kingdom
Dimensions:
Height: 254mm,
Width: 178mm,
Weight: 820g
ISBN: 9781032620459
ISBN 10: 1032620455
Pages: 208
Publication Date: 28 May 2024
Audience:
College/higher education
,
Professional and scholarly
,
Primary
,
Undergraduate
Format: Hardback
Publisher's Status: Active
Chapter 1 Introduction to metronomic chemotherapy Chapter 2 Metronomic chemotherapy- a multi-targeted therapy Chapter 3 Conventional chemotherapeutic vs. metronomic chemotherapy Chapter 4 The anti-angiogenic basis of metronomic chemotherapy Chapter 5 Imaging techniques, biomarkers, and methods for metronomic chemotherapy Chapter 6 Metronomic chemotherapy in breast cancer Chapter 7 Metronomic chemotherapy in combination with anticancer vaccines Chapter 8 Metronomic: towards personalized chemotherapy Chapter 9 Metronomic chemotherapy for metastatic breast cancer Chapter 10 Recent Advances, challenges, and future of metronomic chemotherapy Chapter 11 Targeted therapies in combination with metronomic chemotherapy Chapter 12 Recent advances in metronomic chemotherapy: nanotechnology-based low-dose chemotherapy in breast cancer Index
Dr. Manzoor Ahmad Mir holds Master’s Degree in Zoology with Gold Medal from HNBG Central University and after qualifying prestigious National level CSIR-JRF-NET examination; he worked jointly for his PhD at Jawaharlal Nehru University New Delhi and CSIR-Institute of Microbial Technology Chandigarh in the field of Immunopathology. His basic research interests include, molecular immunology and Immunobiology of microbes (MTB). His PhD research title was “Role of co-stimulation in the survival of intracellular pathogens”. He currently teaches Cancer Biology, and Immunology at the Department of Bioresources, School of Biological Sciences, University of Kashmir. He is presently heading the Department of Bioresources, University of Kashmir.